1. Home
  2. CTOR

CTOR

CITIUS ONCOLOGY INC

as 09-16-2024 2:33pm EST

$
-
.
-
-
-
$
-
.
-
-
-
.
-
-
%

Stocks

NYSE

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.
Founded: 2021 Country:
United States
United States
Employees: N/A City: NEW YORK
Market Cap: 126.2M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 167.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.29 EPS Growth: N/A
52 Week Low/High: $1.53 - $49.00 Next Earning Date: 08-12-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest CITIUS ONCOLOGY INC News

CTOR Breaking Stock News: Dive into CTOR Ticker-Specific Updates for Smart Investing

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire

11 days ago

Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

All CTOR News

Compare CTOR vs Leading Stocks

CTOR VS MCRB

CTOR VS RAPT

CTOR VS RGLS

CTOR VS CZWI

CTOR VS CRDL

CTOR VS ANVS

CTOR VS CATO

CTOR VS CKPT

Share on Social Networks:

Free Stock Ticker Widget

Embed our stock ticker widget on your website.

Stock Traders Forum

Community for stock traders to ask questions, gain insights, and learn.

Stock Alerts on Telegram

Subscribe to our Telegram channel for stock tips & insights.

Similar to CTOR Stocks: